KNDS N.V. | Finanzwire

Basculer en Français

10761	Companies
231314	Keywords
159730	Articles
122986	Press releases

Home
Companies
KNDS N.V.

BRIEF

published on 07/01/2026 at 20:45, 21 days 1 hour ago

KNDS Awaits Favorable Market Conditions to Resume IPO

Investor Relations Market Conditions IPO KNDS European Defense
PRESS RELEASE

published on 07/01/2026 at 20:40, 21 days 1 hour ago

KNDS to resume its Initial Public Offering process when Capital Markets conditions are supportive
KNDS announces to resume IPO process once favorable market conditions return due to current European Defense sector volatility. Company has strong order backlog, growth, and innovation focus

Market Conditions IPO Initial Public Offering KNDS European Defense
BRIEF

published on 06/24/2026 at 09:42, 28 days 12 hours ago

KNDS Announces IPO Plan to Fuel Long-Term Growth

Revenue Growth IPO Defense Technology European Markets German Investment
PRESS RELEASE

published on 06/24/2026 at 09:37, 28 days 12 hours ago

KNDS ANNOUNCES INTENTION TO PROCEED WITH AN IPO TO SUPPORT ITS LONG-TERM GROWTH STRATEGY
KNDS announces intention to proceed with an IPO to support its long-term growth strategy, becoming a unique European pure-play land defense champion with strong Franco-German foundations

Growth Strategy IPO KNDS Land Defense European Defense

Accesswire

Published on 07/22/2026 at 15:00, 7 hours 26 minutes ago

Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 7 hours 26 minutes ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:50, 7 hours 36 minutes ago

Hillcrest Enters AI Datacenter Ecosystem
Published on 07/22/2026 at 14:35, 7 hours 51 minutes ago

Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 7 hours 56 minutes ago

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

View all ACCESSWIRE

EQS Group

Published on 07/22/2026 at 21:01, 1 hour 24 minutes ago

EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 20:45, 1 hour 40 minutes ago

Increase in Equity to Accelerate Growth
Published on 07/22/2026 at 20:44, 1 hour 41 minutes ago

EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on July 22, 2026
Published on 07/22/2026 at 20:08, 2 hours 17 minutes ago

EQS-Adhoc: FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 19:35, 2 hours 50 minutes ago

Stabilus SE: Invitation to a web conference on Q3 FY2026 results on August 3, 2026

Les Echos

Published on 07/22/2026 at 18:19, 4 hours 7 minutes ago

Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 4 hours 41 minutes ago

Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:40, 4 hours 46 minutes ago

Report on share repurchases from 15 to 21 July 2026
Published on 07/22/2026 at 08:03, 14 hours 22 minutes ago

Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:00, 14 hours 26 minutes ago

Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy

View all LES ECHOS COMFI WIRE